NKTR
Nektar Therapeutics
Price:  
0.90 
USD
Volume:  
22,344,688.00
United States | Pharmaceuticals
Valuation
Overview
Financials
Forecast
Compare
Historical Price
SolvencyDividends
Transactions
People

NKTR Relative Valuation

-2297.4%
Upside

As of 2024-03-05, the Relative Valuation of Nektar Therapeutics (NKTR) is (19.78) USD. This relative valuation is based on P/E multiples. With the latest stock price at 0.90 USD, the upside of Nektar Therapeutics based on Relative Valuation is -2297.4%.

The range of the Relative Valuation is (16.93) - (20.81) USD.

Note: valuation result may not be accurate due to the company's negative earnings.

Range Selected
Trailing P/E multiples 11.0x - 13.5x 12.8x
Forward P/E multiples 7.9x - 13.7x 12.9x
Fair Price (16.93) - (20.81) (19.78)
Upside -1981.0% - -2412.0% -2297.4%
0.90 USD
Stock Price
(19.78) USD
Fair Price

NKTR Relative Valuation - Historical P/E Data

Date P/E
2024-03-04 -0.58
2024-03-01 -0.51
2024-02-29 -0.46
2024-02-28 -0.47
2024-02-27 -0.49
2024-02-26 -0.44
2024-02-23 -0.44
2024-02-22 -0.43
2024-02-21 -0.45
2024-02-20 -0.43
2024-02-16 -0.46
2024-02-15 -0.48
2024-02-14 -0.50
2024-02-13 -0.43
2024-02-12 -0.46
2024-02-09 -0.46
2024-02-08 -0.45
2024-02-07 -0.44
2024-02-06 -0.44
2024-02-05 -0.36
2024-02-02 -0.36
2024-02-01 -0.38
2024-01-31 -0.35
2024-01-30 -0.36
2024-01-29 -0.36
2024-01-26 -0.33
2024-01-25 -0.33
2024-01-24 -0.33
2024-01-23 -0.33
2024-01-22 -0.33
2024-01-19 -0.35
2024-01-18 -0.36
2024-01-17 -0.32
2024-01-16 -0.34
2024-01-12 -0.35
2024-01-11 -0.35
2024-01-10 -0.36
2024-01-09 -0.36
2024-01-08 -0.38
2024-01-05 -0.35
2024-01-04 -0.37
2024-01-03 -0.36
2024-01-02 -0.39
2023-12-29 -0.37
2023-12-28 -0.36
2023-12-27 -0.33
2023-12-26 -0.34
2023-12-22 -0.33
2023-12-21 -0.31
2023-12-20 -0.31